MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening

• Main Authors: Isabel N. Schellinger (Author), Markus Wagenhäuser (Author), Giriprakash Chodisetti (Author), Karin Mattern (Author), Angelika Dannert (Author), Anne Petzold (Author), Joanna Jakubizka-Smorag (Author), Fabian Emrich (Author), Josephina Haunschild (Author), Andreas Schuster (Author), Elisabeth Schwob (Author), Kei Schulz (Author), Lars Maegdefessel (Author), Joshua M. Spin (Author), Michael Stumvoll (Author), Gerd Hasenfuß (Author), Philip S. Tsao (Author), Uwe Raaz (Author)
• Format: Book
• Published: Elsevier, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients with type 2 diabetes (T2D) are threatened by excessive cardiovascular morbidity and mortality. While accelerated arterial stiffening may represent a critical mechanistic factor driving cardiovascular risk in T2D, specific therapies to contain the underlying diabetic arterial remodeling have...